CD4+CD25+regulatory T cells: a therapeutic target for liver diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CD4+CD25+regulatory T cells: a therapeutic target for liver diseases

Published:2008-02-13 Issue:3 Volume:12 Page:313-326
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Zheng Ming-Hua,Gu Dian-Na,Braddock Martin,Leishman Andrew J,Jin Chang,Wen Jin-Sheng,Gong Yue-Wen,Chen Yong-Ping

Publisher

Informa Healthcare

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/14728222.12.3.313

Reference185 articles.

1. Central Tolerance of T Cells

2. A very high level of crossreactivity is an essential feature of the T-cell receptor

3. Regulatory T Cells in Autoimmmunity

4. Regulatory T cells in the control of immune pathology

5. Induction and mechanism of action of transforming growth factor-β-secreting Th3 regulatory cells

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leveraging metformin to combat hepatocellular carcinoma: its therapeutic promise against hepatitis viral infections;Journal of Cancer Metastasis and Treatment;2024-01-23

2. CD4⁺CD25⁺ regulatory T cells decreased future liver remnant after associating liver partition and portal vein ligation for staged hepatectomy;World Journal of Gastrointestinal Surgery;2023-05-27

3. Hepatocellular carcinoma in viral and autoimmune liver diseases: Role of CD4+ CD25+ Foxp3+ regulatory T cells in the immune microenvironment;World Journal of Gastroenterology;2021-06-14

4. CD4+CD25+Foxp3+ Regulatory T Cells Contribute in Liver Fibrosis Improvement with Interferon Alpha;Inflammation;2013-06-28

5. CD25 Is a Novel Marker of Hepatic Bile Canaliculus;International Journal of Surgical Pathology;2012-05-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3